Multiple endocrine neoplasias are rare hereditary syndromes some of them with malignant
potential. Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant hereditary …

Neuroendocrine neoplasms (NENs) are relatively rare neoplasms with 6.4-times increasing
age-adjusted annual incidence during the last four decades. NENs arise from …

Somatostatin receptor imaging is a valuable tool in the diagnosis, follow-up, and treatment
planning of neuroendocrine tumor (NET). PET-based tracers using 68Ga as the radioisotope …

Importance Compared with the general population, patients with schizophrenia have a 2-to
3-fold higher mortality rate primarily caused by cardiovascular disease. Previous …

The use of positron emitter–labeled compounds for somatostatin receptor imaging (SRI) has
become attractive because of the prospect of improved spatial resolution, accelerated …

Peptide receptor radionuclide therapy (PRRT) is an established treatment of metastatic
neuroendocrine tumors grade 1–2 (G1–G2). However, its possible benefit in high-grade …

Neuroendocrine tumors (NETs) can be visualized using radiolabeled somatostatin analogs.
We have previously shown the clinical potential of 64Cu-DOTATATE in a small first-in …

Objective Nonexposed osteonecrosis of the jaws (NE-ONJ) does not fit into the current
definition of osteonecrosis, which requires exposed bone. A modification of the classification …

PACAP38 is an endogenous peptide located in trigeminal perivascular nerve fibers in the
brain. It reduces neuronal loss and infarct size in animal stroke models and has been …

Objective: To compare the rate of positive resection margins between radioactive seed
localization (RSL) and wire-guided localization (WGL) after breast conserving surgery …